Melanoma Stage IV
Showing 1 - 25 of >10,000
Melanoma Stage III, Melanoma Stage IV Trial in San Francisco (Binimetinib, Imatinib)
Recruiting
- Melanoma Stage III
- Melanoma Stage IV
-
San Francisco, CaliforniaUniversity of California, San Francisco
Dec 6, 2022
Liquid Biopsy, Melanoma (Skin), Melanoma Stage III Trial in Rome (Affinity Mediated Transport Amplification (AMT))
Recruiting
- Liquid Biopsy
- +4 more
- Affinity Mediated Transport Amplification (AMT)
-
Rome, Italy"Regina Elena" National Cancer Institute
Jul 13, 2023
Melanoma Stage Iii, Melanoma Stage Iv, Melanoma Trial in Chapel Hill (Denosumab, Pembrolizumab, Nivolumab)
Active, not recruiting
- Melanoma Stage Iii
- +4 more
- Denosumab
- +2 more
-
Chapel Hill, North CarolinaUNC Lineberger Comprehensive Cancer Center
Jul 20, 2022
Melanoma Stage III, Melanoma Stage IV, Inoperable Disease Trial in Tampa (Interleukin-2, Ipilimumab, Nivolumab)
Recruiting
- Melanoma Stage III
- +2 more
- Interleukin-2
- +2 more
-
Tampa, FloridaMoffitt Cancer Center
Dec 6, 2022
Patients With Stage 0-IV Melanoma in Real Clinical Practice
Recruiting
- Melanoma
- +7 more
- surgery (any volume) and / or pharmaceuticals treatment initiated or planned or only dynamic observation, in accordance with current clinical guidelines
-
Moscow, Russian FederationN.N. Blokhin Russian Cancer Research Center
Jun 12, 2022
Participation Patterns Among Stage IV Melanoma Patients
Not yet recruiting
- Stage IV Melanoma
-
San Francisco, CaliforniaPower Life Sciences
Oct 16, 2023
Cancer, Melanoma Stage III, Melanoma Stage IV Trial (KB707)
Not yet recruiting
- Cancer
- +6 more
- KB707
- (no location specified)
Jul 24, 2023
Cutaneous Melanoma, Stage III, Cutaneous Melanoma, Stage IV, Merkel Cell Carcinoma Trial (IFx-Hu2.0)
Available
- Cutaneous Melanoma, Stage III
- +3 more
- IFx-Hu2.0
- (no location specified)
Aug 5, 2022
Cutaneous Melanoma, Stage III, Cutaneous Melanoma, Stage IV Trial in Tampa (IFx-Hu2.0)
Completed
- Cutaneous Melanoma, Stage III
- Cutaneous Melanoma, Stage IV
- IFx-Hu2.0
-
Tampa, FloridaH. Lee Moffitt Cancer Center
Aug 5, 2022
Melanoma, Melanoma Stage IV, Metastatic Melanoma Trial in Gothenburg (Surgical metastasectomy, Immunotherapy)
Recruiting
- Melanoma
- +3 more
- Surgical metastasectomy
- Immunotherapy
-
Gothenburg, SwedenSahlgrenska University Hospital
May 3, 2022
Melanoma (Skin), Melanoma Stage IV, Melanoma, Uveal Trial in Rochester ([203Pb]VMT01, [68Ga]VMT02)
Recruiting
- Melanoma (Skin)
- +3 more
-
Rochester, MinnesotaMayo Clinic
Aug 5, 2022
Leptomeningeal Metastasis, NSCLC Stage IV, Melanoma Stage IV Trial in Geneva, St Gallen, Zurich (intrathecal nivolumab and
Recruiting
- Leptomeningeal Metastasis
- +2 more
- intrathecal nivolumab and intrathecal ipilimumab
-
Geneva, Switzerland
- +2 more
Dec 18, 2022
Melanoma Stage III, Melanoma Stage IV Trial in Louisville (Beta-Glucan)
Recruiting
- Melanoma Stage III
- Melanoma Stage IV
- Beta-Glucan
-
Louisville, KentuckyUniversity of Louisville
Jan 7, 2022
Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8 Trial in Shanghai (Endostar,
Recruiting
- Clinical Stage III Cutaneous Melanoma AJCC v8
- Clinical Stage IV Cutaneous Melanoma AJCC v8
-
Shanghai, ChinaFudan University Shanghai Cancer Center
Jun 17, 2023
Melanoma Stage III, Melanoma Stage IV Trial in Amsterdam (Fecal microbiota transplantation)
Recruiting
- Melanoma Stage III
- Melanoma Stage IV
- Fecal microbiota transplantation
-
Amsterdam, NetherlandsAntoni van Leeuwenhoek
Jul 8, 2022
Melanoma Stage III, Melanoma Stage IV Trial in Amsterdam (T-VEC)
Recruiting
- Melanoma Stage III
- Melanoma Stage IV
-
Amsterdam, NH, NetherlandsAntoni van Leeuwenhoek ziekenhuis
Feb 11, 2022
Melanoma Stage III, Melanoma Stage IV Trial in Jette (Regorafenib 40 MG Oral Tablet)
Not yet recruiting
- Melanoma Stage III
- Melanoma Stage IV
- Regorafenib 40 MG Oral Tablet
-
Jette, Brussel, BelgiumUZ Brussels
May 6, 2022
Malignant Melanoma, Melanoma (Skin), Melanoma Stage III Trial in United Kingdom (SCIB1 DNA vaccine)
Recruiting
- Malignant Melanoma
- +3 more
- SCIB1 DNA vaccine
-
Cardiff, United Kingdom
- +6 more
Dec 7, 2022
Melanoma Stage III, Melanoma Stage IV, BRAF V600 Mutation Trial in Tampa (Encorafenib Pill, Binimetinib Pill, Nivolumab)
Recruiting
- Melanoma Stage III
- +2 more
- Encorafenib Pill
- +2 more
-
Tampa, FloridaMoffitt Cancer Center
May 27, 2022
Stage III Malignant Melanoma of Skin AJCC V6, Stage IV Malignant Melanoma of Skin Trial in Santiago (TAPCells vaccine)
Completed
- Stage III Malignant Melanoma of Skin AJCC V6
- Stage IV Malignant Melanoma of Skin
- TAPCells vaccine
-
Santiago, RM, ChileFaculty of Medicine, University of Chile
Nov 21, 2023
Metastatic Melanoma, Stage III Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7 Trial in Rochester (drug,
Active, not recruiting
- Metastatic Melanoma
- +6 more
- Ibrutinib
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 13, 2023
Malignant Melanoma, Metastatic Melanoma, Immunotherapy Trial (Pembrolizumab, Encorafenib, Binimetinib)
Not yet recruiting
- Malignant Melanoma
- +4 more
- Pembrolizumab
- +2 more
- (no location specified)
Mar 31, 2022
NSCLC Stage IV, Melanoma Stage IV, Unresectable Melanoma Trial in Montréal (Camu Camu Capsules (Camu Camu powder encapsulated
Recruiting
- NSCLC Stage IV
- +3 more
- Camu Camu Capsules (Camu Camu powder encapsulated (500mg each) + ICI
-
Montréal, Quebec, CanadaCentre hospitalier de l'Université de Montréal (CHUM)
Jul 18, 2022